Glaucoma Drainage Devices Market Report 2023 (Global Edition)

Global Glaucoma Drainage Devices Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Glaucoma Drainage Devices Industry growth. Glaucoma Drainage Devices market has been segmented with the help of its Type, Application , and others. Glaucoma Drainage Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Glaucoma Drainage Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Glaucoma Drainage Devices Market, by type

Implants & Shunts

Glaucoma drainage implants are small prosthetic devices that are placed to help lower the intraocular pressure and prevent further optic nerve damage. Glaucoma drainage implant surgery is an alternative to Glaucoma Filtration Surgery (Trabeculectomy). In some patients, particularly those with certain types of glaucoma such as aphakic glaucoma, neovascular glaucoma, and uveitic glaucoma, trabeculectomies are known to be less successful at reducing intraocular pressure due to an aggressive healing response. Also, in patients who have had other eye surgeries, a glaucoma drainage device often works better than a trabeculectomy procedure to control the intraocular pressure.One type of incisional glaucoma surgery uses a tube shunt, which is a flexible glaucoma drainage device that is implanted in the eye to divert aqueous humor (the fluid inside the eye) from the inside of the eye to an external reservoir. Aqueous shunts are artificial filtering devices which lower the intraocular pressure (IOP) by draining aqueous humor to the external subconjunctival space. Aqueous shunts are increasingly utilized in the management of refractory glaucoma.

MIGS

Minimally Invasive Glaucoma Surgery or ‘MIGS’ is a term applied, more or less appropriately, to the widening range of implants, devices and techniques that seek to lower intraocular pressure with less surgical risk than the more established procedures (of trabeculectomy, non-penetrating procedures (deep sclerectomy, canaloplasty, viscocanulostomy etc.) and tube drainage devices.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Glaucoma Drainage Devices Industry. Request a Free Sample PDF!

Glaucoma Drainage Devices Market, by application

Hospitals

Hospital, an institution that is built, staffed, and equipped for the diagnosis of disease; for the treatment, both medical and surgical, of the sick and the injured; and for their housing during this process. The modern hospital also often serves as a centre for investigation and for teaching. To better serve the wide-ranging needs of the community, the modern hospital has often developed outpatient facilities, as well as emergency, psychiatric, and rehabilitation services.

Physicians (Clinics)

Clinic, an organized medical service offering diagnostic, therapeutic, or preventive outpatient services. Being an outpatient means that you can go home after you receive care. Clinics can be privately operated or publicly managed and funded. They typically cover the primary care needs of populations in local communities, in contrast to larger hospitals which offer more specialized treatments and admit inpatients for overnight stays. While many clinics offer more general healthcare services, some clinics are more specialized. These types of clinics may be focused on areas like mental health, sexual health, or addiction services.

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Glaucoma Drainage Devices market report 2023 Edition by contacting our team.

Glaucoma Drainage Devices Market Regional Analysis

Region and country analysis section of Glaucoma Drainage Devices Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Glaucoma Drainage Devices market.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Company Profile:

Allergan Plc

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. Allergan PLC manufactures specialty pharmaceuticals. The company develops, manufactures, and distributes generic, brand, and over-the-counter products. Allergan offers its pharmaceutical drugs around the world. Allergan is now part of AbbVie.

Glaukos Corporation

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world's leading causes of blindness. They have developed a proprietary bio-activated pharmaceutical therapy for the treatment of a corneal disorder, keratoconus that was approved by the U.S. Food and Drug Administration (FDA) in 2016. They are also developing a pipeline of surgical devices, sustained pharmaceutical therapies, and implantable biosensors intended to treat glaucoma progression, corneal disorders such as keratoconus, dry eye and refractive vision correction, and retinal diseases such as neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME). Our commercial solutions and development-stage product candidates include: 
•    MIGS products that involve the insertion of a micro-scale device or drug delivery system designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathway for patients suffering from glaucoma and MIGS biosensors to measure pressure within the eye
•    Topical pharmaceuticals that are bio-activated on the eye by one of our proprietary systems intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders or refractive disorders
•    Topical pharmaceuticals that are applied to the eyelid and meant to treat dry eye and other conditions
•    Proprietary micro-invasive, bio-erodible sustained release drug delivery implants that are designed to elute pharmaceuticals over time to improve the vision of patients impacted by retinal diseases such as AMD, DME, retinal vein occlusion (RVO), and diabetic retinopathy (DR).

Top Companies Market Share in Glaucoma Drainage Devices Industry: (In no particular order of Rank)

• Alcon
• Henan Universe IOL Researching
• Glaukos Corporation
• Allergan Plc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..